Insmed
INSM
INSM
98 hedge funds and large institutions have $831M invested in Insmed in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 17 closing their positions.
Holders
98
Holders Change
-8
Holders Change %
-7.55%
% of All Funds
2.62%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
9
Increased
39
Reduced
28
Closed
17
Calls
$5.69M
Puts
$3.02M
Net Calls
+$2.67M
Net Calls Change
-$1.11M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$76.2M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$135M |
| 3 |
EA
3
Emerald Advisers
Leola,
Pennsylvania
|
$14.5M |
| 4 |
4
Goldman Sachs
New York
|
$7.5M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$10.6M |
Top Sellers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$5.81M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$23.2M |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$1.42M |
| 4 |
SAM
4
Senzar Asset Management
New York
|
$8.62M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$3.34M |
